DELAYED VISUAL MATURATION

This adverse event was reported 16 times

These drugs are most commonly taken by patients reporting DELAYED VISUAL MATURATION:

# Drug Count
0 DIAZEPAM 7
1 DIAZEPAM ORAL 7
2 DIAZEPAM ORAL SOLUTION (CONCENTRATE) 7
3 METHADONE 7
4 AMISULPRIDE 5
5 LANSOPRAZOLE 5
6 QUETIAPINE 5
7 QUETIAPINE FUMARATE 3
8 BEVACIZUMAB 1
9 FISH OIL 1
See all common drugs associated with DELAYED VISUAL MATURATION

DELAYED VISUAL MATURATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMISULPRIDE 5 0.0008
1 METHADONE 7 0.0002
2 DIAZEPAM ORAL 7 0.0001
3 DIAZEPAM 7 0.0001
4 LANSOPRAZOLE 5 0.0000
5 QUETIAPINE 5 0.0000
6 FISH OIL 1 0.0000
7 MORPHINE SULFATE 1 0.0000
8 BEVACIZUMAB 1 0.0000
9 LEVETIRACETAM 1 0.0000
See all drugs enriched for association with DELAYED VISUAL MATURATION

DELAYED VISUAL MATURATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dopamine-2 Receptor Antagonist [EPC] 5 0.0006
1 Benzodiazepine [EPC] 7 0.0000
2 Proton Pump Inhibitor [EPC] 5 0.0000
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
4 Atypical Antipsychotic [EPC] 2 0.0000
5 Vitamin D [EPC] 1 0.0000
6 Vitamin B12 [EPC] 1 0.0000
7 Vitamin C [EPC] 1 0.0000
See all drug classes enriched for association with DELAYED VISUAL MATURATION